200 related articles for article (PubMed ID: 31178150)
1. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
Harding BN; Delaney JA; Urban RR; Weiss NS
Gynecol Oncol; 2019 Aug; 154(2):426-431. PubMed ID: 31178150
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive medication use and ovarian cancer survival.
Huang T; Townsend MK; Dood RL; Sood AK; Tworoger SS
Gynecol Oncol; 2021 Nov; 163(2):342-347. PubMed ID: 34556331
[TBL] [Abstract][Full Text] [Related]
3. Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients.
Cho MA; Jeong SY; Sohn I; Kim MS; Kang JH; Paik ES; Lee YY; Choi CH
Cancer Res Treat; 2020 Apr; 52(2):645-654. PubMed ID: 32019281
[TBL] [Abstract][Full Text] [Related]
4. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.
Htoo PT; Stürmer T; Jonsson-Funk M; Pate V; Simpson RJ; Lund JL
Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009
[TBL] [Abstract][Full Text] [Related]
5. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
[TBL] [Abstract][Full Text] [Related]
6. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis.
Balkrishnan R; Desai RP; Narayan A; Camacho FT; Flausino LE; Chammas R
Cancer Med; 2021 Aug; 10(15):5347-5357. PubMed ID: 34184420
[TBL] [Abstract][Full Text] [Related]
7. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort.
Padwal R; Mamdani M; Alter DA; Hux JE; Rothwell DM; Tu K; Laupacis A
Diabetes Care; 2004 Oct; 27(10):2458-63. PubMed ID: 15451916
[TBL] [Abstract][Full Text] [Related]
9. Association between antihypertensive medication and the risk of urinary tract infection (UTI) of outpatients: a retrospective cohort study.
Gremke N; Kostev K; Kalder M
Infection; 2023 Apr; 51(2):417-424. PubMed ID: 35906337
[TBL] [Abstract][Full Text] [Related]
10. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
[TBL] [Abstract][Full Text] [Related]
12. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
13. Combination antihypertensive therapy among patients with COPD.
Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive drug therapies and the risk of ischemic stroke.
Klungel OH; Heckbert SR; Longstreth WT; Furberg CD; Kaplan RC; Smith NL; Lemaitre RN; Leufkens HG; de Boer A; Psaty BM
Arch Intern Med; 2001 Jan; 161(1):37-43. PubMed ID: 11146696
[TBL] [Abstract][Full Text] [Related]
15. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
Raebel MA; Zeng C; Cheetham TC; Smith DH; Feigelson HS; Carroll NM; Goddard K; Tavel HM; Boudreau DM; Shetterly S; Xu S
Am J Epidemiol; 2017 Feb; 185(4):264-273. PubMed ID: 28186527
[TBL] [Abstract][Full Text] [Related]
16. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
[TBL] [Abstract][Full Text] [Related]
17. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
18. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL
J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive medication use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000 to 2002.
Lopez J; Meier J; Cunningham F; Siegel D
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1095-9. PubMed ID: 15607614
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
